Rethinking models of psychotropic drug action (Q34411673)

2 August 2017

1 reference

title

Rethinking models of psychotropic drug action (English)

1 reference

2 August 2017

1

Joanna Moncrieff

1 reference

2 August 2017

David Cohen

2

1 reference

2 August 2017

publication date

1 January 2005

1 reference

Psychotherapy and Psychosomatics

2 August 2017

published in

1 reference

2 August 2017

volume

74

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

145-153

1 reference

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

2 August 2017

cites work

1 reference

Initiation and adaptation: a paradigm for understanding psychotropic drug action

21 January 2018

1 reference

Antidepressant-anxiolytic interactions: involvement of the benzodiazepine-GABA and serotonin systems

21 January 2018

1 reference

Neurochemical brain imaging investigations of schizophrenia

21 January 2018

1 reference

Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital

21 January 2018

1 reference

Evaluation of tranquilizing drugs in the management of acute mental disturbance.

21 January 2018

1 reference

Benzodiazepines in the treatment of schizophrenia: a review and reappraisal

21 January 2018

1 reference

Are antidepressants overrated? A review of methodological problems in antidepressant trials

21 January 2018

1 reference

Major tranquillisers used as antidepressants. A review

21 January 2018

1 reference

Suspended judgment. Seeing through the double-masked design: a commentary.

21 January 2018

1 reference

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

21 January 2018

1 reference

The Northwick Park "functional" psychosis study: diagnosis and treatment response

21 January 2018

1 reference

Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data

21 January 2018

1 reference

Relapse into mania or depression following lithium discontinuation: a 7-year follow-up

21 January 2018

1 reference

Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic

21 January 2018

1 reference

A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers

21 January 2018

1 reference

Effects of lithium on vigilance, psychomotoric performance and mood

21 January 2018

1 reference

Functional effects of agents differentially selective to noradrenergic or serotonergic systems

21 January 2018

1 reference

A Multidimensional Test Approach for the Description of the CNS Activity of Drugs in Human Pharmacology

21 January 2018

1 reference

A common role for psychotropic medications: memory impairment

21 January 2018

1 reference

Assessing antidepressant activity in rodents: recent developments and future needs

21 January 2018

1 reference

Psychometric theory is an obstacle to the progress of clinical research

21 January 2018

1 reference

The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

21 January 2018

1 reference

Getting what you ask for: on the selectivity of depression rating scales

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000083999

1 reference

2 August 2017

1 reference